Gene expression profiles with cDNA microarray reveal RhoGDI as a predictive marker for paclitaxel resistance in ovarian cancers.

Source:http://linkedlifedata.com/resource/pubmed/id/16596196

Download in:

View as

General Info

PMID
16596196